rs111033450
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_206933.4(USH2A):āc.6347A>Gā(p.His2116Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000338 in 1,613,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. H2116H) has been classified as Likely benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000586 AC: 147AN: 251030Hom.: 0 AF XY: 0.000472 AC XY: 64AN XY: 135682
GnomAD4 exome AF: 0.000298 AC: 436AN: 1461274Hom.: 0 Cov.: 31 AF XY: 0.000263 AC XY: 191AN XY: 726944
GnomAD4 genome AF: 0.000723 AC: 110AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000699 AC XY: 52AN XY: 74416
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 29, 2021 | This variant is associated with the following publications: (PMID: 20507924) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | USH2A: BP4 - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jun 18, 2018 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 04, 2011 | His2116Arg in exon 33 of USH2A: This variant has not been reported in the litera ture, but has been identified by our laboratory in one family. However, the abse nce of segregation with hearing loss in that family suggests that this variant i s more likely benign. In addition, this variant is not highly conserved across m ammals and has been identified in 0.1% of control chromosomes (rs111033450). - |
USH2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 28, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at